2,4-Bis(benzyloxy)pyrimidin-5-ylboronic acid

Catalog No. :
ACKNMO953
CAS No. :
70523-24-9
Molecular Formula :
C18H17BN2O4
Molecular Weight :
336.16

IUPAC Name:(2,4-bis(benzyloxy)pyrimidin-5-yl)boronic acid

2,4-Bis(benzyloxy)pyrimidin-5-ylboronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$99.00Login to see priceIn stockInquiry
5g98%$346.00Login to see priceIn stockInquiry
25g98%$1214.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,4-Bis(benzyloxy)pyrimidin-5-ylboronic acid
IUPAC Name(2,4-bis(benzyloxy)pyrimidin-5-yl)boronic acid
MDL No.MFCD01318938
Molecular FormulaC18H17BN2O4
Molecular Weight336.16
SMILESOB(O)C1=CN=C(OCC2=CC=CC=C2)N=C1OCC1=CC=CC=C1
InChI KeyHVVGEQHZGHNHJD-UHFFFAOYSA-N
Synonym70523-24-9 | 2,4-BIS(BENZYLOXY)PYRIMIDINE-5-BORONIC ACID | 2,4-bis(benzyloxy)pyrimidin-5-ylboronic acid | [2,4-bis(phenylmethoxy)pyrimidin-5-yl]boronic Acid | (2,4-bis(benzyloxy)pyrimidin-5-yl)boronic acid | 2,4-Bis(benzyloxy)pyrimidin-5-ylboronic acid;2,4-Bis(benz
CAS No.70523-24-9
PubChem CID2735514

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P302+P352-P305+P351+P338-P321-P405-P501

Synthetic Route by SureRoute

1. ACKNMO953 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKNMO953 route product structure diagram
    ACKNMO95370523-24-9 In Stock
Inquiry

2. ACKNMO953 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKNMO953 route product structure diagram
    ACKNMO95370523-24-9 In Stock
Inquiry

Comments (0)